Insider Transactions in Q1 2024 at Cme Group Inc. (CME)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 26
2024
|
William R Shepard Director |
BUY
Open market or private purchase
|
Indirect |
282
+0.11%
|
$60,348
$214.71 P/Share
|
|
Mar 26
2024
|
William R Shepard Director |
BUY
Open market or private purchase
|
Direct |
12
+0.51%
|
$2,568
$214.71 P/Share
|
|
Mar 15
2024
|
Timothy Francis Mc Court Sr MD Global Head Equity & FX |
SELL
Payment of exercise price or tax liability
|
Direct |
383
-2.82%
|
$83,111
$217.5 P/Share
|
|
Mar 15
2024
|
Timothy Francis Mc Court Sr MD Global Head Equity & FX |
BUY
Open market or private sale
|
Direct |
556
+7.49%
|
$120,652
$217.5 P/Share
|
|
Mar 15
2024
|
Ken Vroman Chief Transformation Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,449
-5.49%
|
$531,433
$217.5 P/Share
|
|
Mar 15
2024
|
Ken Vroman Chief Transformation Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,292
+19.09%
|
$1,148,364
$217.5 P/Share
|
|
Mar 15
2024
|
Lynne Fitzpatrick Sr MD Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
329
-1.15%
|
$71,393
$217.5 P/Share
|
|
Mar 15
2024
|
Lynne Fitzpatrick Sr MD Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
559
+3.75%
|
$121,303
$217.5 P/Share
|
|
Mar 15
2024
|
Derek Sammann Sr MD Gl Hd Commodity & Option |
SELL
Payment of exercise price or tax liability
|
Direct |
3,014
-18.27%
|
$654,038
$217.5 P/Share
|
|
Mar 15
2024
|
Derek Sammann Sr MD Gl Hd Commodity & Option |
BUY
Grant, award, or other acquisition
|
Direct |
6,803
+29.2%
|
$1,476,251
$217.5 P/Share
|
|
Mar 15
2024
|
Suzanne Sprague Sr MD Global Head of Clearing |
SELL
Payment of exercise price or tax liability
|
Direct |
330
-2.21%
|
$71,610
$217.5 P/Share
|
|
Mar 15
2024
|
Suzanne Sprague Sr MD Global Head of Clearing |
BUY
Grant, award, or other acquisition
|
Direct |
561
+6.93%
|
$121,737
$217.5 P/Share
|
|
Mar 15
2024
|
Jack J Tobin MD Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
638
-1.36%
|
$138,446
$217.5 P/Share
|
|
Mar 15
2024
|
Jack J Tobin MD Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
541
+2.24%
|
$117,397
$217.5 P/Share
|
|
Mar 15
2024
|
Sunil Cutinho Chief Information Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,183
-9.74%
|
$690,711
$217.5 P/Share
|
|
Mar 15
2024
|
Sunil Cutinho Chief Information Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,183
+18.02%
|
$1,558,711
$217.5 P/Share
|
|
Mar 15
2024
|
Hilda Harris Piell Sr MD & Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,603
-6.67%
|
$564,851
$217.5 P/Share
|
|
Mar 15
2024
|
Hilda Harris Piell Sr MD & Chief HR Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,047
+13.42%
|
$1,312,199
$217.5 P/Share
|
|
Mar 15
2024
|
Julie Winkler Sr MD Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,847
-8.33%
|
$617,799
$217.5 P/Share
|
|
Mar 15
2024
|
Julie Winkler Sr MD Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,425
+15.82%
|
$1,394,225
$217.5 P/Share
|
|
Mar 15
2024
|
Terrence A Duffy Chairman and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
20,095
-15.75%
|
$4,360,615
$217.5 P/Share
|
|
Mar 15
2024
|
Terrence A Duffy Chairman and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
45,359
+26.23%
|
$9,842,903
$217.5 P/Share
|
|
Mar 15
2024
|
Jonathan L Marcus Sr MD General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
282
-5.45%
|
$61,194
$217.5 P/Share
|
|
Mar 15
2024
|
Julie Holzrichter Sr MD Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,350
-8.02%
|
$726,950
$217.5 P/Share
|
|
Mar 15
2024
|
Julie Holzrichter Sr MD Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,560
+15.33%
|
$1,640,520
$217.5 P/Share
|
|
Mar 07
2024
|
Jack J Tobin MD Chief Accounting Officer |
SELL
Bona fide gift
|
Direct |
72
-0.31%
|
-
|
|
Jan 31
2024
|
Timothy Francis Mc Court Sr MD Global Head Equity & FX |
SELL
Open market or private sale
|
Direct |
35
-0.54%
|
$7,210
$206.78 P/Share
|
|
Jan 18
2024
|
William R Shepard Director |
BUY
Open market or private purchase
|
Indirect |
1,331
+0.52%
|
$268,862
$202.44 P/Share
|
|
Jan 18
2024
|
William R Shepard Director |
BUY
Open market or private purchase
|
Direct |
58
+2.44%
|
$11,716
$202.44 P/Share
|